Abirateron Viatris 500 mg
Abirateron Viatris 500 mg is a medicine authorised by Swissmedic under authorisation number 68890. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 September 2022 and the authorisation is limited until 28 September 2027. ATC code L02BX03 places the medicine in the group Endocrine therapy.
| Authorisation number | 68890 |
|---|---|
| Name | Abirateron Viatris 500 mg |
| Full name | Abirateron Viatris 500 mg, Filmtabletten |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BX03 |
| First authorisation | 29 September 2022 |
| Authorisation validity | 28 September 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Abirateron Viatris 500 mg, Filmtabletten | B | 29 September 2022 |
| 2 | Abirateron Viatris 1000 mg, Filmtabletten | B | 29 September 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 56 | Tablette(n) | L02BX03 | 07.16.2. | B |
| 2 | 28 | Tablette(n) | L02BX03 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Abirateron Viatris 500 mg authorised in Switzerland?
Yes. Abirateron Viatris 500 mg is authorised by Swissmedic under authorisation number 68890, data as of 01 September 2026. The authorisation is limited until 28 September 2027.
Which dispensing category does Abirateron Viatris 500 mg have?
Abirateron Viatris 500 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Abirateron Viatris 500 mg?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.